CATHERINE CZAJA: Open Payments
NPI 1073183364 · TINLEY PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,117 in 100 payments from 21 companies in 2025. Trend: 2023 $2,449 · 2024 $1,676 · 2025 $2,117
Food & beverage: $1,896Education: $221
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $472 |
| GlaxoSmithKline, LLC. | 27 | $428 |
| Regeneron Healthcare Solutions, Inc. | 5 | $168 |
| Actelion Pharmaceuticals US, Inc. | 8 | $139 |
| Verona Pharma, Inc. | 6 | $118 |
| Insmed, Inc. | 5 | $114 |
| JAZZ PHARMACEUTICALS INC. | 3 | $90 |
| Amgen Inc. | 3 | $76 |
| Baxter Healthcare | 4 | $72 |
| United Therapeutics Corporation | 3 | $70 |
Products named: NUCALA, TEZSPIRE, DUPIXENT, TRELEGY ELLIPTA, FASENRA, Ohtuvayre, Arikayce, OPSUMIT.
Industry payments across IL — which companies pay providers there.
